Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 51079-210

12 FDA label images from Mylan Institutional Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 51079-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin Calcium Structural Formula (Image 01)

Atorvastatin Calcium Structural Formula (Image 01)
Chemical structure of atorvastatin calcium, showing the molecular arrangement including calcium ions and associated hydration, from the FDA SPL label.*
FDA Label Image

Atorvastatin Calcium 10 mg Tablets Unit Carton Label (Image 02)

Atorvastatin Calcium 10 mg Tablets Unit Carton Label (Image 02)
Atorvastatin Calcium 10 mg film-coated tablets packaging label showing the dosage strength and a small image of an oval white tablet imprinted with '10'. The label includes NDC 51079-208-20, states 'Tablets, USP', and specifies a quantity of 100 tablets (10 x 10). It is manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV, made in India, with storage instructions and a barcode displayed.*
FDA Label Image

Atorvastatin Calcium 40 mg Tablets Unit Carton Label (Image 03)

Atorvastatin Calcium 40 mg Tablets Unit Carton Label (Image 03)
Atorvastatin Calcium 20 mg film-coated tablets packaging label. The label shows the tablet is white and oval-shaped with '20' imprinted. The label includes the NDC 51079-209-20, indicates 100 tablets (10 x 10) per package, and is manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV. Storage instructions specify 20° to 25°C. The label notes that each tablet contains atorvastatin calcium equivalent to 20 mg atorvastatin.*
FDA Label Image

Unit Carton (Image 04)

Unit Carton (Image 04)
Atorvastatin Calcium 40 mg film-coated tablets label showing the dosage strength and tablet imprint '40'. The label includes a barcode, dosage information, storage instructions, and packaging size of 100 tablets (10 x 10). Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV, the label also specifies Rx only and origin as made in India.*
FDA Label Image

Atorvastatin Calcium 80 mg Tablets Unit Carton Label (Image 05)

Atorvastatin Calcium 80 mg Tablets Unit Carton Label (Image 05)
Label for Atorvastatin Calcium tablets, USP 80 mg film-coated oral tablets. The label shows the strength 80 mg prominently and includes NDC 51079-211-03, quantity of 30 tablets (5 x 6), and Rx only indication. Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV, made in India. Storage instructions and usual dosage note are also visible.*
FDA Label Image

Unit Carton (Image 06)

Unit Carton (Image 06)
A line graph showing cumulative incidence percentage over time in years, comparing Atorvastatin and Placebo groups. The graph includes a hazard ratio (HR=0.64 [0.50-0.83]) and p-value (0.0005), indicating statistical data related to the comparison.*
FDA Label Image

Atorvastatin Calcium 20 mg Tablets Unit Carton Label (Image 07)

Atorvastatin Calcium 20 mg Tablets Unit Carton Label (Image 07)
A line graph comparing the cumulative hazard percentage over time in years to first primary endpoint between atorvastatin and placebo groups over a four-year follow-up period. The graph shows lower cumulative hazard in the atorvastatin group compared to placebo throughout the duration.*
FDA Label Image

Unit Carton (Image 08)

Unit Carton (Image 08)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over a five-year period for Atorvastatin 10 mg and 80 mg doses. The x-axis shows time in years to the first major cardiovascular endpoint, and the y-axis shows the percentage of subjects experiencing the event. The graph includes hazard ratio and p-value statistics.*
FDA Label Image

Unit Carton (Image 09)

Unit Carton (Image 09)
Atorvastatin Calcium unit-dose packaging label. The blue label includes safety warnings that the package is not child resistant and intended for institutional use only. It is distributed by Mylan Institutional Inc., Rockford, IL. The label features a window for the lot number and expiration date, along with a QR code and printed text for tracking.*
FDA Label Image

Image 10

Image 10
Blue unit-dose packaging label for Atorvastatin Calcium tablets distributed by Mylan Institutional Inc. The label includes text on safety and usage warnings, a visible window for lot number and expiration date, and a QR code with lot and expiration information. The packaging is designed for institutional use and features the Mylan logo and address.*
FDA Label Image

Image 11

Image 11
Unit-dose blue packaging label for Atorvastatin Calcium film-coated tablets distributed by Mylan Institutional Inc. The label includes usage warnings such as not child resistant, for institutional use only, and storage advice. It features a window for lot number and expiration date, with a QR code on the back.*
FDA Label Image

Image 12

Image 12
Blue unit-dose packaging for Atorvastatin Calcium oral film-coated tablets, distributed by Mylan Institutional Inc. The label includes instructions indicating the package is not child-resistant and intended for institutional use. A lot number and expiration date are visible through a window on the package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.